784 filings
8-K
ABT
Abbott Laboratories
17 Apr 24
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
7:36am
ARS
2023 FY
ABT
Abbott Laboratories
15 Mar 24
Annual report to shareholders
4:05pm
DEFA14A
ABT
Abbott Laboratories
15 Mar 24
Additional proxy soliciting materials
4:04pm
DEF 14A
ABT
Abbott Laboratories
Definitive proxy
15 Mar 24
4:03pm
10-K
2023 FY
ABT
Abbott Laboratories
Annual report
16 Feb 24
4:15pm
8-K
cu6i8w1k3yq4232k8jt
29 Jan 24
Entry into a Material Definitive Agreement
4:10pm
8-K
dvjnxwi
24 Jan 24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
7:36am
8-K
sr5wyp
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
8-K/A
h6zigj
1 Sep 23
Submission of Matters to a Vote of Security Holders
4:13pm
8-K
clf8db zi8d
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
8-K
sqxfk5
12 Jun 23
Departure of Directors or Certain Officers
10:32am
8-K/A
an6gveos9ry
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
SD
sx4g9a9vnq8y
31 May 23
Conflict minerals disclosure
2:08pm
S-3ASR
c8w6wi6ncgwjuw
3 May 23
Automatic shelf registration
6:13am
8-K
t9qa9oa 1jq
2 May 23
Submission of Matters to a Vote of Security Holders
6:00am
8-K
91nvq9 qc5snt2ci2
19 Apr 23
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
7:25am
PX14A6G
1e28iqko
10 Apr 23
Letter to shareholders
11:53am